"Klinické centrum ISCARE a.s.. poskytuje specializované lékařské výkony již od roku 1995. Najdete u nás centrum reprodukční medicíny, klinické a výzkumné centrum pro střevní záněty, centrum jednodenní chirurgie, centrum ortopedie, centrum revmatologie, centrum andrologie a centrum žilní chirurgie."

During the past decade, ISCARE a.s. conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 14 clinical trials were completed, i.e. on average, 43.8% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 14 clinical trials were completed. i.e. 155.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "ISCARE a.s." #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Celgene" with 5 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored, "Eli Lilly and Company" with 4 trials sponsored and "Janssen-Cilag Ltd." with 4 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "ISCARE a.s." #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "ISCARE a.s." are "Ulcerative Colitis" (16 trials), "Crohn Disease" (9 trials), "Colitis, Ulcerative" (4 trials), "Crohn's Disease" (4 trials) and "Fistulizing Crohns Disease" (1 trials). Many other conditions were trialed in "ISCARE a.s." in a lesser frequency.

Most popular intervention types in "ISCARE a.s." are "Drug" (31 trials), "Other" (7 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Etrolizumab" (5 trials), "Guselkumab" (5 trials), "Etrasimod" (3 trials) and "Mirikizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "ISCARE a.s." are 32 trials for "All" genders.

Currently, there are NaN active trials in "ISCARE a.s.". undefined are not yet recruiting, 10 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in ISCARE a.s., undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in ISCARE a.s., 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

ISCARE a.s. has several departments that took part in Clinical trials: "ISCARE a.s. (Klinicke centrum ISCARE), Klinicke a vyzkumne centrum pro strevni zanety" - 3 trials